631900-75-9

Basic information

• Product Name: 2-Cyclopenten-1-one, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(3,4,5-trimethoxyphenyl)-
• CAS NO: 631900-75-9
• Molecular Formula: C20H30O5Si
• Molecular Weight: 378.541
• Mol File: 631900-75-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-Cyclopenten-1-one, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(3,4,5-trimethoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Cyclopenten-1-one, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(3,4,5-trimethoxyphenyl)-(631900-75-9)
• EPA Substance Registry System: 2-Cyclopenten-1-one, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(3,4,5-trimethoxyphenyl)-(631900-75-9)

Safety Data

• Hazardous Substances Data: 631900-75-9(Hazardous Substances Data)

Upstream product

• 86-81-7 3,4,5-trimethoxy-benzaldehyde 
• 631900-71-5 α-(3,4,5-trimethoxyphenyl)-2-furanmethanol 
• 631900-73-7 4-hydroxy-2-(3,4,5-trimethoxyphenyl)cyclopent-2-en-1-one 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 631900-81-7 4-(tert-butyldimethylsilanyloxy)-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-cyclopent-2-en-1-one 
• 936717-84-9 4-(tert-butyldimethylsilanyloxy)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)cyclopent-2-en-1-ol 
• 1027945-52-3 C₃₀H₄₀O₈Si 
• 631900-85-1 C₂₉H₄₀O₆Si 
• 631901-37-6 C₂₁H₂₂O₆ 
• 631901-41-2 5-(tert-butyldimethylsilanyloxy)-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)cyclopent-2-en-1-one 
• 631900-95-3 4-acetoxy-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-cyclopent-2-en-1-one 
• 631900-99-7 4-hydroxy-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-cyclopent-2-en-1-one oxime 
• 631900-80-6 4-hydroxy-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)cyclopent-2-en-1-one 

Relevant articles and documents

Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent- 2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents

A new series of 2,3-diaryl-4/5-hydroxy-cyclopent-2-en-1-one analogues replacing the cis double bond of combretastatin A-4 (CA-4) by 4/5-hydroxy cyclopentenone moieties was designed and synthesized. The analogues displayed potent cytotoxic activity (ICsub

Cyclopentenone derivatives for cancer therapy

The invention relates to the use of derivatives of cyclopentenone for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the u